VJHemOnc is committed to improving our service to you

EBMT 2020 | Safety and outcome of prophylactic high-dose donor CD45RO+ memory T-cells after allo-HSCT

VJHemOnc is committed to improving our service to you

Mercedes Gasior Kabat

Mercedes Gasior Kabat, MD, Hospital Universitario La Paz, Madrid, Spain, discusses prophylactic high-dose donor CD45RO+ memory T-cell infusion after allogeneic hemopoietic stem cell transplantation (allo-HSCT), focusing on safety and outcomes. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter